
|Videos|March 10, 2016
Future Landscape of Antidiabetic Agents for Type 2 Diabetes
Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.
Advertisement
Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5














































































































































































































